(Q48792378)

15 February 2018

title

Sertraline and relapse prevention training following treatment by very-low-calorie diet: a controlled clinical trial. (English)

1 reference

15 February 2018

1 reference

1 reference

2

1 reference

15 February 2018

author name string

Wadden TA

1

1 reference

15 February 2018

Foster GD

3

1 reference

15 February 2018

Greenstein RA

4

1 reference

15 February 2018

Wingate BJ

5

1 reference

15 February 2018

Stunkard AJ

6

1 reference

15 February 2018

Letizia KA

7

1 reference

15 February 2018

publication date

1 November 1995

1 reference

15 February 2018

published in

Obesity

1 reference

15 February 2018

volume

3

1 reference

15 February 2018

issue

6

1 reference

15 February 2018

page(s)

549-557

1 reference

15 February 2018

An Inventory for Measuring Depression

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00189.X

Use and abuse of appetite-suppressant drugs in the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00189.X

DENSITOMETRIC ANALYSIS OF BODY COMPOSITION: REVISION OF SOME QUANTITATIVE ASSUMPTIONS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00189.X

Fluoxetine: a randomized clinical trial in the maintenance of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00189.X

Dexfenfluramine in the treatment of severe obesity: a placebo-controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00189.X

Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00189.X

Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00189.X

Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00189.X

New methods for calculating metabolic rate with special reference to protein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00189.X

Year-long weight loss treatment for obese patients with type II diabetes: does including an intermittent very-low-calorie diet improve outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00189.X

10.1002/J.1550-8528.1995.TB00189.X

21 January 2018

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018